Shots: The approval is based on the results of two international P-III 108 and 110 study assessing Vemlidy vs Viread in 1,632 patients with HBeAg-negative and HBeAg-positive HBV disease for […]readmore
Tags : Chronic Hepatitis B Virus (HBV) Infection
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Boehringer Ingelheim
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Lilly
Merck
Novartis
P-III
patients
Pfizer
receives
Regeneron
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
Treat
Treatment
US